Brief: Adial Pharmaceuticals Awarded Notice Of Allowance For Key Patent Combining Use Of The Company’S Proprietary Genetic Diagnostic With Ad04 To Treat Alcohol And Drug Dependence

Azora Therapeutics

19/10/2023 18:17

Oct 19 (Reuters) - Adial Pharmaceuticals Inc  ADIL.O :
    * ADIAL PHARMACEUTICALS AWARDED NOTICE OF ALLOWANCE FOR KEY
PATENT
COMBINING USE OF THE COMPANY’S PROPRIETARY GENETIC DIAGNOSTIC
WITH AD04 TO TREAT ALCOHOL AND DRUG DEPENDENCE

Source text for Eikon:  ID:nGNX4n2w6T 
Further company coverage:  ADIL.O 

 ((Reuters.Briefs@thomsonreuters.com;))